Cargando…
Abstract 33: Clinical exome sequencing in XY DSD
Background: XY DSD presents as a diagnostic dilemma, making genetic tests essential for diagnosis. Aims and Objectives: Determine diagnostic yield of clinical exome sequencing in XY DSD patients &Ascertain concordance between clinical diagnosis and genetic diagnosis in case of XY DSD. Results: 3...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067718/ http://dx.doi.org/10.4103/2230-8210.342147 |
_version_ | 1784700067286876160 |
---|---|
author | Das, Debaditya Chowdhury, Subhankar |
author_facet | Das, Debaditya Chowdhury, Subhankar |
author_sort | Das, Debaditya |
collection | PubMed |
description | Background: XY DSD presents as a diagnostic dilemma, making genetic tests essential for diagnosis. Aims and Objectives: Determine diagnostic yield of clinical exome sequencing in XY DSD patients &Ascertain concordance between clinical diagnosis and genetic diagnosis in case of XY DSD. Results: 39 patients were included in this observational study. Mean age at presentation was 7.5 years. Consanguinity was present in 23 cases (59%) and 24 (61.5%) were reared as males. The median External Masculinization Score was 3/12. Commonest clinical/biochemical and genetic diagnosis was partial androgen insensitivity syndrome in 17 Patients (43.6%) and 5 patients (22.7%) respectively. Clinical Exome detected mutation in 22 cases (56.4%). In 10 cases (45.45%) the variant was pathogenic. 4 (18%) cases showed a likely pathogenic variant and 8 cases (36%) showed variant of unknown significance. Discordance between clinical and genetic diagnoses was seen in 6 (27.27%) of cases. In 17 (43.6%) cases, we failed to detect any genetic abnormalities. Conclusion: Although clinical exome sequencing picked up 56.4% of cases, it led to change in diagnosis in 27.27% cases which potentially could alter management and improve clinical outcomes. However clinical exome failed to detect mutations in significant proportion of patients. |
format | Online Article Text |
id | pubmed-9067718 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-90677182022-05-05 Abstract 33: Clinical exome sequencing in XY DSD Das, Debaditya Chowdhury, Subhankar Indian J Endocrinol Metab Abstracts … Esicon 2021 Background: XY DSD presents as a diagnostic dilemma, making genetic tests essential for diagnosis. Aims and Objectives: Determine diagnostic yield of clinical exome sequencing in XY DSD patients &Ascertain concordance between clinical diagnosis and genetic diagnosis in case of XY DSD. Results: 39 patients were included in this observational study. Mean age at presentation was 7.5 years. Consanguinity was present in 23 cases (59%) and 24 (61.5%) were reared as males. The median External Masculinization Score was 3/12. Commonest clinical/biochemical and genetic diagnosis was partial androgen insensitivity syndrome in 17 Patients (43.6%) and 5 patients (22.7%) respectively. Clinical Exome detected mutation in 22 cases (56.4%). In 10 cases (45.45%) the variant was pathogenic. 4 (18%) cases showed a likely pathogenic variant and 8 cases (36%) showed variant of unknown significance. Discordance between clinical and genetic diagnoses was seen in 6 (27.27%) of cases. In 17 (43.6%) cases, we failed to detect any genetic abnormalities. Conclusion: Although clinical exome sequencing picked up 56.4% of cases, it led to change in diagnosis in 27.27% cases which potentially could alter management and improve clinical outcomes. However clinical exome failed to detect mutations in significant proportion of patients. Wolters Kluwer - Medknow 2022-03 /pmc/articles/PMC9067718/ http://dx.doi.org/10.4103/2230-8210.342147 Text en Copyright: © 2022 Indian Journal of Endocrinology and Metabolism https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Abstracts … Esicon 2021 Das, Debaditya Chowdhury, Subhankar Abstract 33: Clinical exome sequencing in XY DSD |
title | Abstract 33: Clinical exome sequencing in XY DSD |
title_full | Abstract 33: Clinical exome sequencing in XY DSD |
title_fullStr | Abstract 33: Clinical exome sequencing in XY DSD |
title_full_unstemmed | Abstract 33: Clinical exome sequencing in XY DSD |
title_short | Abstract 33: Clinical exome sequencing in XY DSD |
title_sort | abstract 33: clinical exome sequencing in xy dsd |
topic | Abstracts … Esicon 2021 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067718/ http://dx.doi.org/10.4103/2230-8210.342147 |
work_keys_str_mv | AT dasdebaditya abstract33clinicalexomesequencinginxydsd AT chowdhurysubhankar abstract33clinicalexomesequencinginxydsd |